News | October 29, 2008

Bard Receives FDA Approval for Flair Endovascular Stent Graft

October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.

The device is comprised of a self-expanding Nitinol stent encapsulated within Bard’s proprietary ePTFE graft material. The Flair Endovascular Stent Graft is indicated to treat stenoses in synthetic arteriovenous bypass grafts. More than 300,000 patients with end-stage renal disease in the U.S. rely on these bypass grafts to receive hemodialysis treatment. These stenoses are the leading cause of bypass graft malfunction, compromising dialysis quality. Typically, multiple interventions, primarily with balloon angioplasty, are necessary to maintain the patency of bypass grafts over their useful lives.

Bard’s six month, prospective, randomized, pivotal study of 190 patients at 16 sites showed that placement of the FlairEndovascular Stent Graft resulted in more than twice the primary patency of balloon angioplasty (50.6 vs. 23.3 percent).

“The Flair Endovascular Stent Graft is the first interventional technology that has demonstrated superiority to balloon angioplasty for maintaining access patency,” said Ziv Haskal M.D., professor of radiology at the University of Maryland and lead investigator of the clinical trial.

This approval is Bard’s first in the U.S. peripheral vascular stent market. The company has two additional PMA applications pending, one for an iliac artery indication for its E-Luminexx Stent and another for a superficial femoral artery indication for the LifeStent FlexStar Stent.

For more information:

Related Content

First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial
News | Stents Peripheral| July 26, 2017
Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK)...
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Artery Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent
News | Stents Peripheral| April 28, 2017
Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting, according to the...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral| March 16, 2017
W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular Stent, a...
TOBA II BTK clinical trial, Intact Vascular, Tack Endovascular System, CLI, critical limb ischemia, first patient treated
News | Stents Peripheral| March 02, 2017
Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK)...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Overlay Init